|
US3539573A
(en)
|
1967-03-22 |
1970-11-10 |
Jean Schmutz |
11-basic substituted dibenzodiazepines and dibenzothiazepines
|
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3630200A
(en)
|
1969-06-09 |
1971-12-28 |
Alza Corp |
Ocular insert
|
|
US3847770A
(en)
|
1972-04-10 |
1974-11-12 |
Continental Can Co |
Photopolymerizable compositions prepared from beta hydroxy esters and polyitaconates
|
|
US3959470A
(en)
|
1972-11-28 |
1976-05-25 |
Mikhail Davidovich Mashkovsky |
Psychotropic medicinal preparation
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4769027A
(en)
|
1984-08-15 |
1988-09-06 |
Burroughs Wellcome Co. |
Delivery system
|
|
GB8607684D0
(en)
|
1986-03-27 |
1986-04-30 |
Ici America Inc |
Thiazepine compounds
|
|
US4687610A
(en)
|
1986-04-30 |
1987-08-18 |
E. I. Du Pont De Neumours And Company |
Low crystallinity polyester yarn produced at ultra high spinning speeds
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5627165A
(en)
*
|
1990-06-13 |
1997-05-06 |
Drug Innovation & Design, Inc. |
Phosphorous prodrugs and therapeutic delivery systems using same
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US5354566A
(en)
|
1993-06-02 |
1994-10-11 |
Kraft General Foods, Inc. |
Preparation of yeast-leavened dough crusts
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US5602124A
(en)
|
1994-12-12 |
1997-02-11 |
Allelix Biopharmaceuticals, Inc. |
5-HT2 receptor ligands
|
|
RU2140417C1
(ru)
*
|
1995-10-17 |
1999-10-27 |
Институт физиологически активных веществ РАН |
Производные гидрированных пиридо(4,3-b)индолов, способы их получения, фармацевтическая композиция и способ лечения
|
|
RU2106864C1
(ru)
*
|
1995-10-23 |
1998-03-20 |
Николай Серафимович Зефиров |
Средство для лечения болезни альцгеймера
|
|
NZ501211A
(en)
|
1999-01-29 |
2001-10-26 |
Pfizer Prod Inc |
Pharmaceutical composition comprising macrolide antibiotic like erythromycin and a Substance P antagonist, and method for treating cancer, bacterial and protozoal infection in non-humans
|
|
US7550143B2
(en)
|
2005-04-06 |
2009-06-23 |
Ibc Pharmaceuticals, Inc. |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
|
|
US6383764B1
(en)
*
|
2000-04-28 |
2002-05-07 |
The Regents Of The University Of California |
Methods of identifying compounds for controlling absence seizures in a mammal relating to prolactin-releasing peptide(PrRP)
|
|
US6613308B2
(en)
*
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
JP2005533009A
(ja)
|
2002-03-28 |
2005-11-04 |
イーライ・リリー・アンド・カンパニー |
ピペラジン置換されたアリールベンゾジアゼピン類およびそのドーパミン受容体アンタゴニストとしての精神病性障害の処置のための使用
|
|
AU2003223538A1
(en)
|
2002-04-11 |
2003-10-27 |
Children's Medical Center Corporation |
Methods for the treatment of cancer
|
|
US20040102525A1
(en)
|
2002-05-22 |
2004-05-27 |
Kozachuk Walter E. |
Compositions and methods of treating neurological disease and providing neuroprotection
|
|
GB0307067D0
(en)
|
2002-12-17 |
2003-04-30 |
Aventis Pharma Inc |
Use of thiazolobenzoheterocycles for treating multiple sclerosis
|
|
US20050065219A1
(en)
|
2003-03-27 |
2005-03-24 |
Lipton Stuart A. |
Treatment of demyelinating conditions
|
|
US20070270429A1
(en)
|
2003-05-06 |
2007-11-22 |
Shiro Shibayama |
Function Inhibitor of Effector Cell
|
|
WO2005009342A2
(en)
|
2003-07-16 |
2005-02-03 |
Pharmacia Corporation |
Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
|
|
US7060723B2
(en)
*
|
2003-08-29 |
2006-06-13 |
Allergan, Inc. |
Treating neurological disorders using selective antagonists of persistent sodium current
|
|
AU2005215767A1
(en)
*
|
2004-02-13 |
2005-09-01 |
Adamas Pharmaceuticals, Inc. |
Combination of an NMDA receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other CNS disorders
|
|
RU2281085C2
(ru)
|
2004-05-25 |
2006-08-10 |
Закрытое акционерное общество "Мастерлек" |
Антидепрессивные лекарственные средства для парентерального применения на основе сульфонатных солей пирлиндола
|
|
EP1688161A1
(en)
|
2004-11-02 |
2006-08-09 |
Switch Biotech Aktiengesellschaft |
Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
|
|
US7790712B2
(en)
|
2005-03-17 |
2010-09-07 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors
|
|
WO2007016353A2
(en)
|
2005-07-28 |
2007-02-08 |
Bristol-Myers Squibb Company |
Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists
|
|
US8802707B2
(en)
|
2005-07-31 |
2014-08-12 |
Trevor Gordon Marshall |
Method of treating and/or preventing cancers using Sartans and/or Statins to modulate VDR, and/or PPAR, and/or GCR and/or CB1 receptors; in conjunction with certain bacteriostatic antibiotics
|
|
US8868172B2
(en)
*
|
2005-12-28 |
2014-10-21 |
Cyberonics, Inc. |
Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
|
|
JP2010501559A
(ja)
|
2006-08-21 |
2010-01-21 |
シンタ ファーマシューティカルズ コーポレーション |
黒色腫の再発を予防するまたは遅らせるのに使用するためのビス（チオヒドラジドアミド）
|
|
CA2664099A1
(en)
|
2006-09-20 |
2008-03-27 |
Medivation Neurology, Inc. |
Methods and compositions for treating amyotrophic lateral sclerosis (als)
|
|
US20080108574A1
(en)
*
|
2006-09-27 |
2008-05-08 |
Braincells, Inc. |
Melanocortin receptor mediated modulation of neurogenesis
|
|
CA2667553A1
(en)
*
|
2006-10-27 |
2008-05-02 |
Medivation Neurology, Inc. |
Methods and combination therapies for treating alzheimer's disease
|
|
WO2008133884A2
(en)
|
2007-04-23 |
2008-11-06 |
Combinatorx, Incorporated |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
JP2010528016A
(ja)
|
2007-05-25 |
2010-08-19 |
メディベーション ニューロロジー， インコーポレイテッド |
細胞を刺激するための方法および組成物
|
|
WO2008156654A2
(en)
|
2007-06-15 |
2008-12-24 |
Massachusetts Institute Of Technology |
Cytoskeleton modulators for treating metabolic disorders
|
|
US20110111014A1
(en)
|
2007-06-26 |
2011-05-12 |
Parkinson's Institute |
Methods and compositions for treatment of neurological disorders
|
|
EP2085120A1
(en)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
The use of substances for the treatment of central or peripheral insulin receptor impairment and insulin resistance
|
|
WO2009135091A1
(en)
|
2008-04-30 |
2009-11-05 |
Medivation Technologies, Inc. |
Use of asenapine and related compounds for the treatment of neuronal or non-neuronal diseases or conditions
|
|
EP2355660A4
(en)
|
2008-10-13 |
2012-05-02 |
Biovista Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
|
|
EP2375900B1
(en)
|
2008-12-11 |
2016-03-02 |
Biovista, Inc. |
Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
|